Navigation Links
US Oncology Ranks 2nd in Affiliate Member Accruals for Radiation Therapy Oncology Group
Date:3/2/2010

;s.tl(this,'o','ExternalLink');" target='_blank' href="http://www.usoncology.com/">US Oncology, Inc. announced today that its wholly-owned subsidiary US Oncology Research, LLC placed second amongst all affiliate members in patients accrued to RTOG clinical trials. US Oncology is the nation's leading oncology services company uniting the nation's largest cancer treatment and research network to expand patient access to high-quality, cost-effective cancer care and advance the science of cancer care. Its US Oncology Research network has played a role in the development of 39 cancer therapies approved by the FDA and remains committed to increasing patient access to advanced therapies that improve patient outcomes and quality of life.

"This is a tremendous accomplishment for the US Oncology Research network and serves to enhance patient care in all the communities we serve," says Vivek Kavadi, M.D. Medical Director of Radiation Oncology at US Oncology and radiation oncologist with Texas Oncology-Sugar Land, an affiliate of US Oncology and a member of the US Oncology Research network. "RTOG offers premier clinical trial opportunities for patients. This high accrual rating puts our radiation oncologists and our cancer centers in a very positive light and showcases how patients can receive optimal cancer care in their own community."


'/>"/>
SOURCE US Oncology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Calif. , July 31, 2014 Touro ... it has been selected as the recipient of a ... which will allow the University to increase research and ... about creating state-of-the-art technology for the study of health ... enhance the diverse needs and interests of our students," ...
(Date:7/31/2014)... , July 31, 2014 For its innovative ... California , Art,s-Way Scientific has earned a Modular ... With competition in over 30 categories, MBI,s contest is ... members, which include building manufacturers, dealers, and product and ... excellent example the capability of our team," said ...
(Date:7/31/2014)... VIENNA , July 31, 2014 ... in New York results of AFF008, ... Parkinson,s disease. PD01A is the first therapy against the protein ... The Michael J. Fox Foundation for Parkinson,s Research ... and presented at the press conference on the impact a ...
Breaking Medicine Technology:Touro University California Garners Grant From Long Foundation 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 2First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 3First Clinical Data of Therapeutic Parkinson's Disease Vaccine Encourages Continued Development 4
(Date:8/1/2014)... (HealthDay News) -- Roaming the high Alps more than ... as the "Ice Man" no doubt had a very tough ... not have shielded the Ice Man, nicknamed Otzi, from a ... for atherosclerosis, or "hardening of the arteries," appears to be ... a new study finds. "Our ancestors going back ...
(Date:8/1/2014)... , Parkinson,s disease affects ... activity ceases and the cells die. Researchers at the Max ... supplying D-lactate or glycolate, two products of the gene DJ-1, ... to cultured HeLa cells and to cells of the nematode ... prevented the degeneration of neurons. They also showed that the ...
(Date:8/1/2014)... 01, 2014 The North America Sports Drink ... North America, with analysis and forecast of revenue. The Sports ... around $5,021.9 million in 2012 to $6,243 million by 2018, ... Browse through the TOC of the North America Sports Drink ... provided. This also provides a glimpse of the segmentation in ...
(Date:8/1/2014)... Gerontological Society of America (GSA) ... field of aging has chosen Madonna Harrington ... PhD, of the University of Luxembourg; and Philipp ... The London School of Economics and Political Science ... Innovative Publication Awards. , These distinguished honors recognize ...
(Date:8/1/2014)... According to Forrester Research, more than 90 ... in search of information, and thanks to the launching of ... information and resources on insurance specifically for the state of ... this next step in the growth of our business,” Doug ... - Commercial Insurance Resources office. “We recognize that the web ...
Breaking Medicine News(10 mins):Health News:'Ice Man' Mummy May Have Been at Risk of Heart Disease 2Health News:Potential treatment and prevention of Parkinson's disease 2Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Harrington Meyer, Leist, Hessel, Avendano to receive GSA's 2014 Kalish awards 2Health News:DCInsurers Agent Doug King Launches a New Website 2Health News:DCInsurers Agent Doug King Launches a New Website 3
... HealthDay Reporter , TUESDAY, Sept. 13 (HealthDay News) -- ... aortic valve live in fear of sudden death, but a ... complication called aortic dissection. However, these people are at ... or bulge in the wall of the aorta, researchers report. ...
... children with autism spectrum disorder (ASD), routine medical procedures ... difficult. Communication and social interaction deficits and reliance on ... the significant factors to be considered when preparing a ... effort to help families and medical providers make necessary ...
... of Boston,s elderly homeless population is emerging from a ... Hebrew SeniorLife, an affiliate of Harvard Medical School. The ... rates of geriatric syndromes, including functional decline, falls, frailty ... that many of these conditions may be easily treated ...
... a widely prescribed class of drugs used to lower cholesterol, ... in people who,ve had strokes, new research finds. Statins ... caused by blocked blood flow to the brain, to reduce ... raised concerns that statins might also raise the risk of ...
... Health and Sanford-Burnham Medical Research Institute (Sanford-Burnham) have ... laboratory scientists uncovering new approaches for treating cancer ... Basic medical research often struggles to achieve ... into medical practice. The field of translational medicine ...
... that taking the anti-inflammatory drug celecoxib can reduce the ... at the cost of increasing the risk of heart ... Researchers at Winship Cancer Institute of Emory University ... cells into suicide, separately from its known effects. The ...
Cached Medicine News:Health News:Heart Defect Seems to Pose Low Risk of Aorta Tear 2Health News:Autism Speaks launches 'blood draw' tool kit -- practical guidance for parents and providers 2Health News:Autism Speaks launches 'blood draw' tool kit -- practical guidance for parents and providers 3Health News:Institute for Aging Research study finds Boston's elderly homeless sicker than others 2Health News:Statins Don't Raise Risk of Brain Bleeds After Stroke: Study 2Health News:Scripps Health and Sanford-Burnham to collaborate to advance new cancer treatments 2Health News:Separating a cancer prevention drug from heart disease risk 2
... Complete includes the nutrients used in the ... Antioxidant Supplement Trial (LAST), which suggested no ... in a one year period. Macula Complete ... in peer-reviewed studies to support the mitochondria, ...
... Soft Gel Lutein patented formula is based ... PreserVision® AREDS formula, with the beta-carotene substituted ... is a carotenoid found in dark leafy ... highly concentrated in the macula, the part ...
... & Lomb PreserVision® AREDS formula is the ... supplement clinically proven effective in the 10-year ... Eye Disease Study (AREDS). , PreserVision® AREDS ... supplement with the antioxidant vitamins A, C, ...
... scientific formulation that provides the foundation ... basic eye-specific nutritional support. All ingredients ... standards, when applicable. ScienceBased Health formulations ... maximum bioavailability, and are free of ...
Medicine Products: